$1.06 Billion is the total value of HARBOURVEST PARTNERS LLC's 56 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
W | Wayfair, Inc. | $271,384,000 | -19.1% | 1,062,126 | 0.0% | 25.49% | -20.5% | |
BHG | Bright Health Group, Inc. | $34,417,000 | -52.4% | 4,217,715 | 0.0% | 3.23% | -53.3% | |
EVLO | Evelo Biosciences, Inc. | $21,567,000 | -48.8% | 3,063,505 | 0.0% | 2.03% | -49.7% | |
RUBY | Rubius Therapeutics, Inc. | $17,645,000 | -26.8% | 986,878 | 0.0% | 1.66% | -28.1% | |
FTCH | Farfetch Ltd.ordinary shares cla | $16,593,000 | -25.6% | 442,716 | 0.0% | 1.56% | -26.8% | |
WHD | Cactus, Inc. | $14,820,000 | +2.7% | 392,896 | 0.0% | 1.39% | +0.9% | |
LC | LendingClub Corp. | $14,500,000 | +55.8% | 513,440 | 0.0% | 1.36% | +53.0% | |
KLDO | Kaleido BioSciences, Inc. | $10,013,000 | -26.6% | 1,833,832 | 0.0% | 0.94% | -27.8% | |
RLAY | Relay Therapeutics, Inc. | $9,346,000 | -13.8% | 296,402 | 0.0% | 0.88% | -15.3% | |
AXLA | Axcella Health, Inc. | $8,368,000 | -25.7% | 2,807,981 | 0.0% | 0.79% | -27.0% | |
TWLO | Twilio, Inc. | $4,649,000 | -19.1% | 14,572 | 0.0% | 0.44% | -20.4% | |
SGTX | Sigilon Therapeutics, Inc. | $4,185,000 | -47.3% | 740,740 | 0.0% | 0.39% | -48.3% | |
CVRX | CVRx, Inc. | $3,531,000 | -40.9% | 213,479 | 0.0% | 0.33% | -41.9% | |
IBRX | ImmunityBio, Inc. | $3,270,000 | -31.8% | 335,709 | 0.0% | 0.31% | -33.0% | |
EB | Eventbrite, Inc. | $2,006,000 | -0.4% | 106,064 | 0.0% | 0.19% | -2.6% | |
LOV | Spark Networks SEsponsored adr | $1,759,000 | -32.2% | 501,026 | 0.0% | 0.16% | -33.5% | |
YEXT | Yext, Inc. | $1,385,000 | -15.8% | 115,147 | 0.0% | 0.13% | -17.2% | |
ROOT | Root, Inc. | $1,077,000 | -51.3% | 204,314 | 0.0% | 0.10% | -52.1% | |
DCT | Duck Creek Technologies, Inc. | $642,000 | +1.7% | 14,508 | 0.0% | 0.06% | 0.0% | |
PACB | Pacific Biosciences of California, Inc. | $600,000 | -26.9% | 23,484 | 0.0% | 0.06% | -28.2% | |
CSLT | Castlight Health, Inc. | $548,000 | -40.3% | 349,070 | 0.0% | 0.05% | -42.0% | |
CTMX | Cytomx Therapeutics, Inc. | $403,000 | -19.6% | 79,193 | 0.0% | 0.04% | -20.8% | |
MCRB | Seres Therapeutics, Inc. | $344,000 | -70.8% | 49,363 | 0.0% | 0.03% | -71.7% | |
ALGS | Aligos Therapeutics, Inc. | $291,000 | -24.0% | 18,783 | 0.0% | 0.03% | -27.0% | |
TRVN | Trevena, Inc. | $288,000 | -27.1% | 233,850 | 0.0% | 0.03% | -28.9% | |
PMVP | PMV Pharmaceuticals | $229,000 | -12.9% | 7,692 | 0.0% | 0.02% | -12.0% | |
YMTX | Yumanity | $227,000 | -11.7% | 22,030 | 0.0% | 0.02% | -16.0% | |
EPZM | Epizyme, Inc. | $126,000 | -38.5% | 24,686 | 0.0% | 0.01% | -40.0% | |
NXTC | NextCure, Inc. | $68,000 | -16.0% | 10,044 | 0.0% | 0.01% | -25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
Trevena, Inc. | 25 | Q4 2021 | 1.2% |
Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
Zuora, Inc. | 21 | Q3 2023 | 3.4% |
Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
LendingClub Corp. | 18 | Q3 2019 | 11.9% |
Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
40-APP | 2024-04-24 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-26 |
13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.